Klingman & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$390K Buy
5,018
+37
+0.7% +$3.06K 0.02% 263
2026
Q2
$422K Buy
4,981
+67
+1% +$5.38K 0.02% 220
2026
Q1
$411K Buy
4,914
+81
+2% +$6.1K 0.02% 217
2025
Q4
$324K Buy
4,833
+192
+4% +$12.4K 0.02% 243
2025
Q3
$314K Buy
4,641
+61
+1% +$4.42K 0.02% 248
2025
Q2
$341K Buy
4,580
+58
+1% +$3.86K 0.02% 227
2025
Q1
$285K Buy
4,522
+349
+8% +$21.6K 0.02% 225
2024
Q4
$238K Buy
4,173
+106
+3% +$6.27K 0.01% 234
2024
Q3
$239K Buy
+4,067
New +$222K 0.01% 246

Other funds holding CTVA

Klingman & Associates's CTVA Position: Q3 2026 in Review

Klingman & Associates increased its Corteva (CTVA) stake by 0.74% in Q3 2026, buying an estimated $3.06K and bringing the position to 5,018 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #263.

Klingman & Associates first reported a position in CTVA in Q3 2024 and has held it in 9 quarters since. The position peaked at $422K in Q2 2026. 477 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Klingman & Associates held 5,018 shares of Corteva worth $390K as of Q3 2026.
  • Klingman & Associates bought 37 Corteva shares in Q3 2026, an estimated $3.06K.
  • Corteva made up 0.02% of Klingman & Associates's portfolio in Q3 2026, its #263 holding.
  • Klingman & Associates first reported a position in Corteva in Q3 2024 and has held it in 9 quarters since.
  • Klingman & Associates's Corteva position peaked at $422K in Q2 2026.
  • 477 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.